Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors

Rosenberg, 1985, Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer, N Engl J Med, 313, 1485, 10.1056/NEJM198512053132327 Goto, 2006, The therapeutic potential of immuno-cell therapy of cancer in combination with aminobisphosphonates, Anticancer Res, 26, 3989 Hirooka, 2009, A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer, Pancreas, 38, 69, 10.1097/MPA.0b013e318197a9e3 Takayama, 2000, Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial, Lancet, 356, 802, 10.1016/S0140-6736(00)02654-4 Ferrarini, 2002, Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer, Trends Immunol, 23, 14, 10.1016/S1471-4906(01)02110-X Sicard, 2005, In vivo immunomanipulation of V gamma 9 V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model, J Immunol, 175, 5471, 10.4049/jimmunol.175.8.5471 Kunzmann, 2000, Stimulation of gamma delta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma, Blood, 96, 384, 10.1182/blood.V96.2.384 Wilhelm, 2003, Gammadelta T cells for immune therapy of patients with lymphoid malignancies, Blood, 102, 200, 10.1182/blood-2002-12-3665 Abe, 2009, Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma, Exp Hematol, 37, 956, 10.1016/j.exphem.2009.04.008 Kobayashi, 2007, Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study, Cancer Immunol Immunother, 56, 469, 10.1007/s00262-006-0199-6 Kondo, 2008, Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy, Cytotherapy, 10, 842, 10.1080/14653240802419328 Goto, 1999, Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunologic dysfunction in advanced cancer patients, Cancer Immunol Immunother, 48, 435, 10.1007/s002620050620 Caccamo, 2005, Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets, Eur J Immunol, 35, 1764, 10.1002/eji.200525983